Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
1AI.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 30, 2025
Report Source: 2025 2nd Quarter Report
Algorae Pharmaceuticals Ltd. Stock Analysis 1AI.AX
Australia Health Care Nano Cap Report: Algorae Pharmaceuticals Ltd. operates as an artificial intelligence enabled drug discovery and development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The Company’s proprietary AI platform, Algorae Operating System (AlgoraeOS), is an AI platform that leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. Its other drug candidates include AI-116, AI-168, NTCELL. AI-116 is a combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer’s disease. AI-168 is a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient, which is conceptualized to be a potential treatment for cardiovascular disease, including hypertension. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.
Read More Algorae Pharmaceuticals Ltd (1AI.AX) Chart
Key Statistics of Algorae Pharmaceuticals Ltd (1AI.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.01Volume
757.47KP/E Ratio (TTM)
-52 Week Range
Market Cap
26.30MAvg. Volume
2.00MDividend Yield
-Financial Metrics & Statements of Algorae Pharmaceuticals Ltd (1AI.AX)
FAQ's for Algorae Pharmaceuticals Ltd (1AI.AX)
- According to Musaffa’s Shariah screening methodology, Algorae Pharmaceuticals Ltd (1AI.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Algorae Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Algorae Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Algorae Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Algorae Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Algorae Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.